Mitochondria-mediated mechanisms of ferroptosis in response to cardiac ischemia-reperfusion injury
线粒体介导的铁死亡响应心脏缺血再灌注损伤的机制
基本信息
- 批准号:10681495
- 负责人:
- 金额:$ 15万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-01 至 2026-08-31
- 项目状态:未结题
- 来源:
- 关键词:AccountingApoptosisAutophagocytosisBiologyCardiacCardiac MyocytesCell DeathCellsCessation of lifeCitric Acid CycleComplexCoronary heart diseaseCysteineCystineDataDependenceDevelopmentEndoplasmic ReticulumExposure toGasesGenerationsGlutamatesHeartImageImaging TechniquesIonsIronIschemiaLipoxygenaseMapsMediatingMitochondriaModelingMolecularMorbidity - disease rateMyocardial InfarctionMyocardial IschemiaMyocardial Reperfusion InjuryMyocardial dysfunctionMyocardiumNecrosisOxidation-ReductionOxidative StressOxidoreductasePathogenesisPhosphatidylethanolaminePhospholipidsPlayPolyunsaturated Fatty AcidsPreventionProcessProductionReduced GlutathioneReducing AgentsReperfusion InjuryReperfusion TherapyResolutionRoleSeveritiesSeverity of illnessSignal TransductionSpectrometry, Mass, Secondary IonSystemTechniquesTherapeuticTherapeutic Interventionantiportercardioprotectioncomparativecoronary perfusiondihydrolipoic acideffectiveness evaluationglutathione peroxidaseheart damagein vivoinhibitorinnovationischemic injurymass spectrometric imagingmortalitynovelnovel therapeutic interventionoxidationpreventresponserestorationselenoproteinspecific biomarkerstherapeutically effectivetreatment strategy
项目摘要
ABSTRACT
Coronary heart disease is the leading cause of mortality and morbidity worldwide that occurs due to the
detrimental effects of myocardial infarction (MI)/ischemia-reperfusion injury (IRI). Mechanisms of MI/IRI
are not completely clear, and hence, there are no effective therapeutic strategies; current therapeutic
approaches to mitigate heart damage mostly focus on restoring coronary perfusion but not limiting
reperfusion injury. Multiple forms of cell death occur at different stages of post-MI/IRI depending on the
severity of the disease. This project will elucidate the regulatory mechanisms of a recently discovered iron-
dependent programmed cell death, ferroptosis, in cardiac IRI. Ferroptosis arises via excessive oxygenation
of phospholipids (PLs) accompanied by the insufficient capacity of a selenoprotein glutathione peroxidase
4 (GPX4) to eliminate oxidized PLs, particularly, phosphatidylethanolamine (PEox) at the expense of
reduced glutathione (GSH). We have recently identified and quantified pro-ferroptotic PEox species in
response to RSL3 (GPX4 inhibitor, ferroptosis inducer) in cardiomyocytes by a state-of-art technique. In
addition, our preliminary studies revealed accumulation of ferroptotic PEox species in mitochondria
isolated from hearts exposed to global IRI as well as from cardiomyocytes challenged with RSL3. We
propose that mitochondria participate in MI/IRI-induced ferroptotic signaling through two major GSH-
dependent mechanisms: i) IR-induced mitochondrial ROS generation by ETC and TCA cycle deplete GSH,
and hence, inactivate the GSH/GPX4 system, and ii) glutamate deficiency due to inhibition of
glutaminolysis in mitochondria inhibits GSH synthesis as a result of low glutamate and cysteine levels.
Thus, this project will explore a novel paradigm by investigating the role of mitochondria in cardiac IRI
ferroptosis. Our central hypothesis is that mitochondria are engaged in ferroptosis induced by cardiac IRI
through diminishing GPX4 activity and inability to control the accumulation of pro-ferroptotic PEox species.
Also, we propose that major cell death mechanisms have different impacts during post-MI/IRI depending
on the severity and duration of post-MI/IRI. Hence, we will evaluate specific biomarkers to distinguish the
contributions of apoptosis, ferroptosis, necroptosis, and pyroptosis to post-MI/IRI. Two approaches will be
employed to mitigate cardiac IRI via i) specific suppression of mtROS production/GSH depletion, and ii)
replenishment of the GSH pool by a potent reductant lipoic/dihydrolipoic acid (LA/DHLA). Specific Aims of
the project will (i) determine comparative contributions of ferroptosis to cardiac dysfunction during IRI, (ii)
explore molecular mechanisms of mitochondria-mediated ferroptotic signaling in cardiac cells, and (iii)
examine the effectiveness of novel inhibitors of ferroptosis against cardiac IRI. The project will establish
the contribution of ferroptosis, in comparison with other major cell death mechanisms, to MI/IRI-induced
cardiac dysfunction, and discover new mitochondria-mediated mechanisms of ferroptotic signaling that will
lead to innovative therapeutic strategies for the treatment of cardiac IRI.
摘要
冠状动脉心脏病是世界范围内死亡率和发病率的主要原因,
心肌梗死(MI)/缺血-再灌注损伤(IRI)的有害作用。MI/IRI的机制
还不完全清楚,因此,没有有效的治疗策略;目前的治疗方法
减轻心脏损伤的方法主要集中在恢复冠状动脉灌注,
再灌注损伤多种形式的细胞死亡发生在MI/IRI后的不同阶段,这取决于
疾病的严重程度。该项目将阐明最近发现的铁的调节机制-
心脏IRI中的依赖性程序性细胞死亡,铁凋亡。过度氧合引起的铁凋亡
磷脂(PLs)伴随硒蛋白谷胱甘肽过氧化物酶能力不足
4(GPX 4)以消除氧化的PL,特别是磷脂酰乙醇胺(PEox),
还原型谷胱甘肽(GSH)。我们最近已经确定和量化的pro-ferroptotic PEox物种,
通过最先进的技术在心肌细胞中对RSL 3(GPX 4抑制剂,铁凋亡诱导剂)的反应。在
此外,我们的初步研究表明,铁中毒PEox物种在线粒体中的积累
分离自暴露于整体IRI的心脏以及用RSL 3攻击的心肌细胞。我们
提出线粒体通过两个主要的GSH-
依赖性机制:i)通过ETC和TCA循环消耗GSH的IR诱导的线粒体ROS产生,
因此,抑制GSH/GPX 4系统,和ii)由于抑制
由于谷氨酸和半胱氨酸水平较低,线粒体中的谷氨酸胺解抑制GSH合成。
因此,本项目将通过研究线粒体在心脏IRI中的作用来探索一种新的范式
铁性下垂我们的中心假设是线粒体参与了心脏IRI诱导的铁凋亡
通过降低GPX 4活性和不能控制促铁蛋白酶PEox物质的积累。
此外,我们提出,在MI/IRI后,主要的细胞死亡机制有不同的影响,
MI/IRI后的严重程度和持续时间。因此,我们将评估特定的生物标志物,以区分
凋亡、铁凋亡、坏死凋亡和焦凋亡对MI/IRI后的作用。两种方法将是
用于通过i)特异性抑制mtROS产生/GSH消耗来减轻心脏IRI,和ii)
通过有效的还原剂硫辛酸/二氢硫辛酸(LA/DHLA)补充GSH库。具体目标
该项目将(i)确定IRI期间铁缺乏症对心功能障碍的比较贡献,(ii)
探索心脏细胞中的神经氨酸介导的铁凋亡信号传导的分子机制,以及(iii)
检查新型铁凋亡抑制剂对心脏IRI的有效性。该项目将建立
与其他主要的细胞死亡机制相比,铁凋亡对MI/IR诱导的细胞凋亡的贡献,
心功能不全,并发现新的神经元介导的铁凋亡信号机制,
导致心脏IRI治疗的创新治疗策略。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Sabzali Javadov其他文献
Sabzali Javadov的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Sabzali Javadov', 18)}}的其他基金
Mitochondria-mediated mechanisms of ferroptosis in response to cardiac ischemia-reperfusion injury
线粒体介导的铁死亡响应心脏缺血再灌注损伤的机制
- 批准号:
10409003 - 财政年份:2022
- 资助金额:
$ 15万 - 项目类别:
Crosstalk between mitochondrial permeability transition and ETC supercomplexes in myocardial infarction
心肌梗死中线粒体通透性转变与 ETC 超复合物之间的串扰
- 批准号:
9207161 - 财政年份:2012
- 资助金额:
$ 15万 - 项目类别:
Mitochondrial Permeability Transition as a Target for Cardioprotection in Heart F
线粒体通透性转变作为心脏 F 心脏保护的目标
- 批准号:
8535195 - 财政年份:2012
- 资助金额:
$ 15万 - 项目类别:
Crosstalk between mitochondrial permeability transition and ETC supercomplexes in myocardial infarction
心肌梗死中线粒体通透性转变与 ETC 超复合物之间的串扰
- 批准号:
9551649 - 财政年份:2012
- 资助金额:
$ 15万 - 项目类别:
Mitochondrial Permeability Transition as a Target for Cardioprotection in Heart F
线粒体通透性转变作为心脏 F 心脏保护的目标
- 批准号:
8676936 - 财政年份:2012
- 资助金额:
$ 15万 - 项目类别:
Crosstalk between mitochondrial permeability transition and ETC supercomplexes in myocardial infarction
心肌梗死中线粒体通透性转变与 ETC 超复合物之间的串扰
- 批准号:
9769807 - 财政年份:2012
- 资助金额:
$ 15万 - 项目类别:
Mitochondrial Permeability Transition as a Target for Cardioprotection in Heart F
线粒体通透性转变作为心脏 F 心脏保护的目标
- 批准号:
9053516 - 财政年份:2012
- 资助金额:
$ 15万 - 项目类别:
Mitochondrial Permeability Transition as a Target for Cardioprotection in Heart F
线粒体通透性转变作为心脏 F 心脏保护的目标
- 批准号:
8337107 - 财政年份:2012
- 资助金额:
$ 15万 - 项目类别:
Mitochondrial Permeability Transition as a Target for Cardioprotection in Heart F
线粒体通透性转变作为心脏 F 心脏保护的目标
- 批准号:
8852176 - 财政年份:2012
- 资助金额:
$ 15万 - 项目类别:
相似国自然基金
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
- 批准号:LBY21H010001
- 批准年份:2020
- 资助金额:0.0 万元
- 项目类别:省市级项目
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
- 批准号:81703335
- 批准年份:2017
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
- 批准号:81670594
- 批准年份:2016
- 资助金额:58.0 万元
- 项目类别:面上项目
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
- 批准号:81470791
- 批准年份:2014
- 资助金额:73.0 万元
- 项目类别:面上项目
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
- 批准号:81301123
- 批准年份:2013
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
- 批准号:81101529
- 批准年份:2011
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
- 批准号:39500043
- 批准年份:1995
- 资助金额:9.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Development of an apoptosis biosensor for monitoring of breast cancer
开发用于监测乳腺癌的细胞凋亡生物传感器
- 批准号:
10719415 - 财政年份:2023
- 资助金额:
$ 15万 - 项目类别:
Milk fat globule-EGF factor 8 and hepatocyte apoptosis-induced liver wound healing response
乳脂肪球-EGF因子8与肝细胞凋亡诱导的肝脏创面愈合反应
- 批准号:
10585802 - 财政年份:2023
- 资助金额:
$ 15万 - 项目类别:
Interrogating the Fgl2-FcγRIIB axis on CD8+ T cells: A novel mechanism mediating apoptosis of tumor-specific memory CD8+ T cells
询问 CD8 T 细胞上的 Fgl2-FcγRIIB 轴:介导肿瘤特异性记忆 CD8 T 细胞凋亡的新机制
- 批准号:
10605856 - 财政年份:2023
- 资助金额:
$ 15万 - 项目类别:
Mechanistic analysis of apoptosis induction by HDAC inhibitors in head and neck cancer
HDAC抑制剂诱导头颈癌凋亡的机制分析
- 批准号:
23K15866 - 财政年份:2023
- 资助金额:
$ 15万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Novel targeted therapy for FGFR inhibitor-resistant urothelial cancer and apoptosis based therapy for urothelial cancer
FGFR抑制剂耐药性尿路上皮癌的新型靶向治疗和基于细胞凋亡的尿路上皮癌治疗
- 批准号:
23K08773 - 财政年份:2023
- 资助金额:
$ 15万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Interrogating the Fgl2-FcgRIIB axis: A novel mechanism mediating apoptosis of tumor-specific memory CD8+ T cells
探究 Fgl2-FcgRIIB 轴:介导肿瘤特异性记忆 CD8 T 细胞凋亡的新机制
- 批准号:
10743485 - 财政年份:2023
- 资助金额:
$ 15万 - 项目类别:
Investigating the role of apoptosis-resistance and the tumor environment on development and maintenance of sacrococcygeal teratomas
研究细胞凋亡抗性和肿瘤环境对骶尾部畸胎瘤发生和维持的作用
- 批准号:
10749797 - 财政年份:2023
- 资助金额:
$ 15万 - 项目类别:
The effects of glucose on immune cell apoptosis and mitochondrial membrane potential and the analysis of its mechanism by which glucose might modulate the immune functions.
葡萄糖对免疫细胞凋亡和线粒体膜电位的影响及其调节免疫功能的机制分析。
- 批准号:
22K09076 - 财政年份:2022
- 资助金额:
$ 15万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
XAF1 IN P53 SIGNALING, APOPTOSIS AND TUMOR SUPPRESSION
P53 信号传导、细胞凋亡和肿瘤抑制中的 XAF1
- 批准号:
10583516 - 财政年份:2022
- 资助金额:
$ 15万 - 项目类别:
Role of Thioredoxin system in regulation of autophagy-apoptosis cross talk in neurons: Uncovering Novel Molecular Interactions.
硫氧还蛋白系统在神经元自噬-凋亡串扰调节中的作用:揭示新的分子相互作用。
- 批准号:
RGPIN-2019-05371 - 财政年份:2022
- 资助金额:
$ 15万 - 项目类别:
Discovery Grants Program - Individual